En español
NIDA

Menu

NIDA Notes Staff

Revised May 2013

Editorial Staff

  • Editor, David Anderson, NIDA
  • Managing Editor, Scott Edie, Ph.D., CSR
  • Associate Editor, Kristin Blank, M.F.A., IQ Solutions
  • Senior Science Writer, Susanne Hiller-Sturmhöfel, Ph.D., CSR
  • Creative Director, Martín Castillo, IQ Solutions
  • Content Coordinator, Stephen Pelkey, CSR

NIDA Notes Editorial Board Members

  • David Anderson, Chair; Public Health Advisor, Office of Science Policy and Communications
  • James Bjork, Ph.D., Program Official, Division of Clinical Neuroscience and Behavioral Research
  • Kristopher Bough, Ph.D., Health Science Administrator, Division of Basic Neuroscience and Behavioral Research
  • Cheryl Boyce, Ph.D., Branch Chief, Division of Clinical Neuroscience and Behavioral Research
  • Redonna Chandler, Ph.D., Chief, Division of Epidemiology, Services, and Prevention Research
  • Petra Jacobs, M.D., Associate Director for Program Development, Center for Clinical Trials Network
  • Diane Lawrence, Ph.D., Health Scientist Administrator, Office of the Director, Aids Research Program
  • Jacqueline Lloyd, Ph.D., Health Science Administrator, Division of Epidemiology, Services and Prevention Research
  • Marsha F. Lopez, Ph.D., Health Science Administrator, Division of Epidemiology, Services and Prevention Research
  • Minda Lynch, Ph.D., Chief, Behavioral and Cognitive Science Research Branch
  • Ivan Montoya, M.D., M.P.H., Medical Officer, Division of Pharmacotherapies and Medical Consequences of Drug Abuse
  • Lisa Onken, Ph.D., Project Officer, Behavioral and Integrative Treatment Branch
  • Mary Pfeiffer, Ph.D., Editor and Writer, Intramural Research Program
  • Nancy Pilotte, Ph.D., Chief, Functional Neuroscience Research Branch
  • Kenzie Preston, Ph.D., Chief, Clinical Pharmacology and Therapeutics Research Branch
  • John Satterlee, Ph.D., Program Director, Division of Basic Neuroscience and Behavioral Research
  • Paul J. Wakim, Ph.D, Senior Mathematical Statistician, Center for Clinical Trials Network
  • Eric Wargo, Ph.D., Science Writer, Office of Science Policy and Communications
  • Cora Lee Wetherington, Ph.D., Psychologist, Division of Basic Neuroscience and Behavioral Research

This page was last updated May 2013

NIDA Notes

Tags

Drug Topics

Drugs of Abuse

Population Groups

Related Topics